Catheters and Active Implantable CDMO Market Size, Share & Trends Analysis Distribution by Service Category (Catheters (Cardiac Catheters, Urology Catheters, Neurovascular Catheters) Active Implantable Devices (Neuromodulation Devices, Structural Heart Devices, Heart Failure Devices, Urology Implantable Devices), Endoscopy Devices), End User- and Segment Forecasts, 2024-2031

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Catheters and Active Implantable CDMO Market Snapshot Chapter 4. Global Catheters and Active Implantable CDMO Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Porter's Five Forces Analysis 4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031 4.8. Global Catheters and Active Implantable CDMO Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031 4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023) 4.10. Use/impact of AI on Catheters and Active Implantable CDMO Industry Trends Chapter 5. Catheters and Active Implantable CDMO Market Segmentation 1: By Service Category, Estimates & Trend Analysis 5.1. Market Share by Service Category, 2023 & 2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Service Category: 5.2.1. Catheters 5.2.1.1. Cardiac Catheters 5.2.1.2. Urology Catheters 5.2.1.3. Neurovascular Catheters 5.2.1.4. Others 5.2.2. Active Implantable Devices 5.2.2.1. Neuromodulation Devices 5.2.2.1.1. Spinal Cord Stimulators 5.2.2.1.2. Deep Brain Stimulators 5.2.2.1.3. Others 5.2.2.2. Structural Heart Devices 5.2.2.2.1. Valve Implants 5.2.2.2.2. Stents and Shunts 5.2.2.2.3. Others 5.2.2.3. Heart Failure Devices 5.2.2.3.1. Percutaneous Left Ventricular Assist Device (LVAD) 5.2.2.3.2. Percutaneous Right Ventricular Support Devices (RVAD) 5.2.2.3.3. Others 5.2.2.4. Urology Implantable Devices 5.2.2.5. Others 5.2.3. Endoscopy Devices 5.2.4. Others Chapter 6. Catheters and Active Implantable CDMO Market Segmentation 2: By End-user, Estimates & Trend Analysis 6.1. Market Share by End-user, 2023 & 2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End-users: 6.2.1. Medical Device OEM Companies 6.2.2. Academic and Research Institutes 6.2.3. Government Agencies Chapter 7. Catheters and Active Implantable CDMO Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. Global Catheters and Active Implantable CDMO Market, Regional Snapshot 2023 & 2031 7.2. North America 7.2.1. North America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 7.2.1.1. US 7.2.1.2. Canada 7.2.2. North America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Category, 2024-2031 7.2.3. North America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031 7.3. Europe 7.3.1. Europe Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 7.3.1.1. Germany 7.3.1.2. U.K. 7.3.1.3. France 7.3.1.4. Italy 7.3.1.5. Spain 7.3.1.6. Rest of Europe 7.3.2. Europe Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Category, 2024-2031 7.3.3. Europe Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031 7.4. Asia Pacific 7.4.1. Asia Pacific Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 7.4.1.1. India 7.4.1.2. China 7.4.1.3. Japan 7.4.1.4. Australia 7.4.1.5. South Korea 7.4.1.6. Hong Kong 7.4.1.7. Southeast Asia 7.4.1.8. Rest of Asia Pacific 7.4.2. Asia Pacific Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Category, 2024-2031 7.4.3. Asia Pacific Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts By End-user, 2024-2031 7.5. Latin America 7.5.1. Latin America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 7.5.1.1. Brazil 7.5.1.2. Mexico 7.5.1.3. Rest of Latin America 7.5.2. Latin America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Category, 2024-2031 7.5.3. Latin America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031 7.6. Middle East & Africa 7.6.1. Middle East & Africa Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 7.6.1.1. GCC Countries 7.6.1.2. Israel 7.6.1.3. South Africa 7.6.1.4. Rest of Middle East and Africa 7.6.2. Middle East & Africa Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Category, 2024-2031 7.6.3. Middle East & Africa Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Integer Holdings Corporation (US) 8.2.1.1. Business Overview 8.2.1.2. Key Product/Service Offerings 8.2.1.3. Financial Performance 8.2.1.4. Geographical Presence 8.2.1.5. Recent Developments with Business Strategy 8.2.2. Cirtec (US) 8.2.3. Biomerics (US) 8.2.4. Switchback Medical (US) 8.2.5. Velentium LLC (US) 8.2.6. Heraeus Group (Germany) 8.2.7. Zeus Company LLC (US) 8.2.8. Veranex (US) 8.2.9. Freudenberg Medical (US) 8.2.10. Medeologix (Taiwan) 8.2.11. Other Prominent Players